Effect of mutant p53 proteins on glycolysis and mitochondrial metabolism

Molecular and Cellular Biology

Volumn 37, Issue 24, 2017, Pages

  Eriksson, Matilda ^a   Ambroise, Gorbatchev ^a   Ouchida, Amanda Tomie ^a   Queiroz, Andre Lima ^a   Smith, Dominique ^a   Gimenez Cassina, Alfredo ^a,b   Iwanicki, Marcin P ^c   Muller, Patricia A ^d   Norberg, Erik ^a   Vakifahmetoglu Norberg, Helin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cancer; EMT; Glycolysis; Metabolism; Mutant p53; OxPhos

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; TP53 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GLYCOLYSIS; HUMAN; HUMAN CELL; MALIGNANT NEOPLASM; MITOCHONDRIAL RESPIRATION; NCI-H1299 CELL LINE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; STABLE EXPRESSION; GENETICS; HCT 116 CELL LINE; METABOLISM; MISSENSE MUTATION; MITOCHONDRION; NEOPLASM; TUMOR CELL LINE;

CELL LINE, TUMOR; GLYCOLYSIS; HCT116 CELLS; HUMANS; MITOCHONDRIA; MUTATION, MISSENSE; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85035762472     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00328-17     Document Type: Article

References (39)

1. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW. 1993. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A 90:4961-4965. https://doi.org/10.1073/pnas.90.11.4961
2. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T. 2004. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119:847-860. https://doi.org/10.1016/j.cell.2004.11.004
3. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA. 1994. Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1-7
4. Oren M, Rotter V. 2010. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol 2:a001107. https://doi.org/10.1101/cshperspect.a001107
5. Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL, Gosselin P, Cromer A, Brugge JS, Sansom OJ, Norman JC, Vousden KH. 2009. Mutant p53 drives invasion by promoting integrin recycling. Cell 139:1327-1341. https://doi.org/10.1016/j.cell.2009.11.026
6. Muller PA, Vousden KH. 2014. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25:304-317. https://doi.org/10.1016/j.ccr.2014.01.021
7. Koppenol WH, Bounds PL, Dang CV. 2011. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325-337. https://doi.org/10.1038/nrc3038
8. DeBerardinis RJ, Chandel NS. 2016. Fundamentals of cancer metabolism. Sci Adv 2:e1600200. https://doi.org/10.1126/sciadv.1600200
9. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674. https://doi.org/10.1016/j.cell.2011.02.013
10. Lunt SY, Vander Heiden MG. 2011. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441-464. https://doi.org/10.1146/annurev-cellbio-092910-154237
11. Kollareddy M, Dimitrova E, Vallabhaneni KC, Chan A, Le T, Chauhan KM, Carrero ZI, Ramakrishnan G, Watabe K, Haupt Y, Haupt S, Pochampally R, Boss GR, Romero DG, Radu CG, Martinez LA. 2015. Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities. Nat Commun 6:7389. https://doi.org/10.1038/ncomms8389
12. Zhang C, Liu J, Liang Y, Wu R, Zhao Y, Hong X, Lin M, Yu H, Liu L, Levine AJ, Hu W, Feng Z. 2013. Tumour-associated mutant p53 drives the Warburg effect. Nat Commun 4:2935. https://doi.org/10.1038/ncomms3935
13. Zhou G, Wang J, Zhao M, Xie TX, Tanaka N, Sano D, Patel AA, Ward AM, Sandulache VC, Jasser SA, Skinner HD, Fitzgerald AL, Osman AA, Wei Y, Xia X, Songyang Z, Mills GB, Hung MC, Caulin C, Liang J, Myers JN. 2014. Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation. Mol Cell 54:960-974. https://doi.org/10.1016/j.molcel.2014.04.024
14. Chavez-Perez VA, Strasberg-Rieber M, Rieber M. 2011. Metabolic utilization of exogenous pyruvate by mutant p53 (R175H) human melanoma cells promotes survival under glucose depletion. Cancer Biol Ther 12: 647-656. https://doi.org/10.4161/cbt.12.7.16566
15. Kalo E, Kogan-Sakin I, Solomon H, Bar-Nathan E, Shay M, Shetzer Y, Dekel E, Goldfinger N, Buganim Y, Stambolsky P, Goldstein I, Madar S, Rotter V. 2012. Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species. J Cell Sci 125:5578-5586. https://doi.org/10.1242/jcs.106815
16. Freed-Pastor WA, Mizuno H, Zhao X, Langerod A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, Borresen-Dale AL, Levine AJ, Bargonetti J, Prives C. 2012. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148:244-258. https://doi.org/10.1016/j.cell.2011.12.017
17. Hanel W, Marchenko N, Xu S, Yu SX, Weng W, Moll U. 2013. Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ 20:898-909. https://doi.org/10.1038/cdd.2013.17
18. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, El-Naggar AK, Lozano G. 2004. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119:861-872. https://doi.org/10.1016/j.cell.2004.11.006
19. Liu DP, Song H, Xu Y. 2010. A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 29:949-956. https://doi.org/10.1038/onc.2009.376
20. Song H, Hollstein M, Xu Y. 2007. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol 9:573-580. https://doi.org/10.1038/ncb1571
21. Ahn CS, Metallo CM. 2015. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab 3:1. https://doi.org/10.1186/s40170-015-0128-2
22. Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. 2017. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun 482:426-431. https://doi.org/10.1016/j.bbrc.2016.11.088
23. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC. 2011. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13:317-323. https://doi.org/10.1038/ncb2173
24. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI. 2011. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelialmesenchymal transition. J Cell Biol 195:417-433. https://doi.org/10.1083/jcb.201103097
25. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. 2011. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 208:875-883. https://doi.org/10.1084/jem.20110235
26. Norberg E, Orrenius S, Zhivotovsky B. 2010. Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochem Biophys Res Commun 396:95-100. https://doi.org/10.1016/j.bbrc.2010.02.163
27. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, Polak K, Tondera D, Gounarides J, Yin H, Zhou F, Green MR, Chen L, Monti S, Marto JA, Shipp MA, Danial NN. 2012. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22:547-560. https://doi.org/10.1016/j.ccr.2012.08.014
28. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, Hofseth LJ, Moake M, Nagashima M, Forrester KS, Harris CC. 2004. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64:2350-2356. https://doi.org/10.1158/0008-5472.CAN-2287-2
29. Pavlova NN, Thompson CB. 2016. The emerging hallmarks of cancer metabolism. Cell Metab 23:27-47. https://doi.org/10.1016/j.cmet.2015.12.006
30. Liu J, Zhang C, Hu W, Feng Z. 2015. Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett 356:197-203. https://doi.org/10.1016/j.canlet.2013.12.025
31. Wang PY, Ma W, Park JY, Celi FS, Arena R, Choi JW, Ali QA, Tripodi DJ, Zhuang J, Lago CU, Strong LC, Talagala SL, Balaban RS, Kang JG, Hwang PM. 2013. Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 368:1027-1032. https://doi.org/10.1056/NEJMoa1214091
32. Wang PY, Li J, Walcott FL, Kang JG, Starost MF, Talagala SL, Zhuang J, Park JH, Huffstutler RD, Bryla CM, Mai PL, Pollak M, Annunziata CM, Savage SA, Fojo AT, Hwang PM. 2017. Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. J Clin Investig 127:132-136. https://doi.org/10.1172/JCI88668
33. Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, ColoffJL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J. 2013. Chaperonemediated autophagy degrades mutant p53. Genes Dev 27:1718-1730. https://doi.org/10.1101/gad.220897.113
34. Xia HG, Najafov A, Geng J, Galan-Acosta L, Han X, Guo Y, Shan B, Zhang Y, Norberg E, Zhang T, Pan L, Liu J, ColoffJL, Ofengeim D, Zhu H, Wu K, Cai Y, Yates JR, Zhu Z, Yuan J, Vakifahmetoglu-Norberg H. 2015. Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death. J Cell Biol 210:705-716. https://doi.org/10.1083/jcb.201503044
35. Wu R, Galan-Acosta L, Norberg E. 2015. Glucose metabolism provide distinct prosurvival benefits to nonsmall cell lung carcinomas. Biochem Biophys Res Commun 460:572-577. https://doi.org/10.1016/j.bbrc.2015.03.071
36. Zhang B, Zheng A, Hydbring P, Ambroise G, Ouchida AT, Goiny M, Vakifahmetoglu-Norberg H, Norberg E. 2017. PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep 19:2289-2303. https://doi.org/10.1016/j.celrep.2017.05.067
37. Peng X, Gimenez-Cassina A, Petrus P, Conrad M, Ryden M, Arner ES. 2016. Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness. Sci Rep 6:28080. https://doi.org/10.1038/srep28080
38. Vaux DL. 2012. Research methods: know when your numbers are significant. Nature 492:180-181
39. Olivier M, Langerod A, Carrieri P, Bergh J, Klaar S, Eyfjord J, Theillet C, Rodriguez C, Lidereau R, Bieche I, Varley J, Bignon Y, Uhrhammer N, Winqvist R, Jukkola-Vuorinen A, Niederacher D, Kato S, Ishioka C, Hainaut P, Borresen-Dale AL. 2006. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 12: 1157-1167